1. Introduction {#sec1-genes-11-00003}
===============

In 1992, researchers discovered the first disease mutation in horses, conferring hyperkalemic periodic paralysis (HYPP) in Quarter Horses \[[@B1-genes-11-00003]\], yet identification of additional equine genetic diseases progressed slowly, with only nine disease-associated variants discovered prior to 2007 \[[@B2-genes-11-00003],[@B3-genes-11-00003]\]. Since the release of the equine reference genome in 2007 \[[@B4-genes-11-00003]\], 22 additional genes were found to cause or be associated with equine diseases, yet there are at least 200 described genetic disorders for which causal variants are unknown \[[@B2-genes-11-00003],[@B5-genes-11-00003]\]. While the majority of characterized equine disease variants are located within coding regions, an increasing amount of research in humans and other animal species suggests that a large number of disease mutations are harbored within regulatory elements and other functional but non-coding regions of the genome \[[@B6-genes-11-00003],[@B7-genes-11-00003],[@B8-genes-11-00003],[@B9-genes-11-00003]\]. Current genomic annotations for the horse have limited information about the functions of these non-coding regions, making it difficult to identify variants that alter gene regulation. While there is a high degree of conservation within coding regions across species, increasing evidence suggests that regulatory regions, especially tissue-specific elements, are not as well conserved in terms of sequence or function across species \[[@B7-genes-11-00003],[@B8-genes-11-00003],[@B9-genes-11-00003],[@B10-genes-11-00003]\].

Using improved annotations of regulatory networks for humans and other mammals, researchers have begun to identify causal variants outside of coding regions. For example, a super-enhancer that significantly contributes to the risk of type II diabetes in humans was identified by combining a genome-wide association study (GWAS) with locations of regulatory elements and other functional regions across the genome \[[@B11-genes-11-00003]\]. Additionally, cattle researchers used annotations from both genomic assays on bovine tissue and homology-based methods to investigate complex traits. They found that the annotation from the homology-based method provided less relevant information than the bovine-specific annotation when combined with GWAS pertaining to milk production \[[@B8-genes-11-00003]\]. Along with the increasing number of regulatory GWAS, researchers are also expanding efforts to look at large-scale changes in the epigenome, such as associations between genome-wide changes in active regulatory elements and autism spectrum disorder \[[@B12-genes-11-00003]\]. With the increasing focus on the importance of regulatory elements in the pathogenesis of many diseases, it is clear that annotations of the equine genome need to encompass both coding and non-coding functional elements in order to understand complex genetic diseases and other traits affecting horses and the equine industry.

Similar to the Encyclopedia of DNA Elements (ENCODE), the Functional Annotation of ANimal Genomes (FAANG) initiative was established to improve the reference annotation of animal species, including characterization of genomic regulatory regions \[[@B13-genes-11-00003],[@B14-genes-11-00003],[@B15-genes-11-00003]\]. The link between chromatin modifications and regulatory regions, such as enhancers and promoters, has been well established for several decades \[[@B16-genes-11-00003]\]. Four histone tail modifications, also known as histone marks, were selected by the FAANG consortium to characterize promoters (H3K4me3) and enhancers (H3K4me1), as well as distinguish between active (H3K27ac) and inactive (H3K27me3) genomic elements \[[@B15-genes-11-00003]\].

Histone tail modifications were first hypothesized to affect genomic regulation in 1964 \[[@B17-genes-11-00003]\]. Since that time, associations between histone marks and regulatory elements have continued to expand. However, it is still unclear if the associations are the result of underlying functional roles in all cases or if the histone marks are the by-products of regulatory activities \[[@B18-genes-11-00003]\]. There is evidence that monomethylation of H3K4 recruits chromatin-modifying proteins to enhancer regions leading to enhancer priming and recognition \[[@B19-genes-11-00003]\]. Conversely, H3K4me3 is associated with promoters and the transcription start site, but some suggest that the mark may actually be a signature left by frequent transcriptional activity to create cellular memory rather than acting as a pioneer factor \[[@B18-genes-11-00003]\]. In conjunction with the H3K4 modifications, acetylation of H3K27 is found at active enhancers and promoters \[[@B20-genes-11-00003]\]. Trimethylation of the same residue, however, is strongly associated with facultative heterochromatin, leading to inactive regulatory elements and silenced genes \[[@B20-genes-11-00003]\]. In fact, these two H3K27 marks are thought to be antagonistic to one another, such that acetylation may actually prevent Polycomb silencing \[[@B21-genes-11-00003]\]. Acetylation of H3K27 also decreases the overall positive charge of the histone proteins, leading to fewer interactions with DNA and more open chromatin structure \[[@B22-genes-11-00003]\]. Since H3K27ac has been strongly associated with active regulatory elements across the genome, presence of this mark can be used to distinguish between active and poised regulatory elements \[[@B23-genes-11-00003]\]. While research into the functional roles of histone tail modifications continues, the associations between these four marks and patterns of regulatory elements are well established. For more than a decade, chromatin immunoprecipitation (ChIP) assays have remained the primary method for identifying genomic sites enriched with histone marks to conduct large-scale regulatory mapping \[[@B24-genes-11-00003],[@B25-genes-11-00003]\].

As part of the international FAANG collaboration, we performed ChIP sequencing (ChIP-Seq) on four major histone modifications (H3K4me1, H3K4me3, H3K27ac, and H3K27me3) in eight equine tissues (adipose, brain (parietal cortex), heart, lamina, liver, lung, (skeletal) muscle, and ovary). These tissues were collected as part of the FAANG equine biobank, which includes samples from 80 tissues, six fluids, and two cell lines that were collected from two healthy adult thoroughbred mares \[[@B26-genes-11-00003]\]. The eight tissues evaluated in this study were prioritized for thorough investigation based on (1) continuity with other FAANG species to enable across species comparisons and/or (2) the primary needs of the equine community in terms of health, performance, and reproduction.

2. Materials and Methods {#sec2-genes-11-00003}
========================

Due to the limited number of previous histone ChIP-Seq experiments across equine tissues, we first performed quality control (QC) testing to determine appropriate experimental parameters for each tissue and mark. Sequencing, rather than targeted qPCR, was used to assess the quality of the QC data due to the limited knowledge of appropriate tissue-specific control genes in the horse. All ChIP-Seq experiments, including QC, were conducted by Diagenode ChIP-Seq Profiling Service (Diagenode, Cat\# G02010000, Liège, Belgium), and a complete summary of the final protocols used for all tissues can be accessed at <ftp://ftp.faang.ebi.ac.uk/ftp/protocols/assays/>. Quality control involved chromatin extraction, ChIP, library preparation, and sequencing of one training sample from each of the eight tissues investigated. Quality control training samples were obtained from previously banked tissues collected at the University of California, Davis. Bioinformatic analysis was performed on the QC data in order to calculate library complexity and ChIP enrichment metrics and to call peaks to evaluate the genomic distribution of detected marks. Library complexity metrics included non-redundant fraction (NRF) and PCR bottleneck coefficients 1 and 2 (PBC1 and PBC2). Metrics for ChIP enrichment included normalized strand cross-correlation coefficient (NSC), relative strand cross-correlation coefficient (RSC), and Jensen--Shannon distance (JSD). Non-redundant fraction, PBC1 and 2, NSC, and RSC are all standardized metrics of the ENCODE project \[[@B27-genes-11-00003]\] and were compared against ENCODE standards to determine the efficacy of the ChIP protocols. Jensen--Shannon distance is a common statistic used to compare two distributions that can be applied to ChIP datasets using deepTools version 2.4.3 \[[@B28-genes-11-00003]\], and a threshold was determined by agreement among FAANG collaborators. Tissues of interest (TOI) used in the final experiments that generated combined peak-calls were collected from two thoroughbred mares (referred to in this manuscript as ECA_UCD_AH1 for SAMEA104728862 and ECA_UCD_AH2 for SAMEA104728877) as part of the FAANG equine biobank \[[@B26-genes-11-00003]\], and all protocols for this work were approved by the University of California, Davis Institutional Animal Care and Use Committee (Protocol \#19037). Laboratory procedures that varied based on tissue are summarized in [Table 1](#genes-11-00003-t001){ref-type="table"}.

2.1. Chromatin Extraction {#sec2dot1-genes-11-00003}
-------------------------

Chromatin was extracted from adipose using the True MicroChIP Kit (Diagenode, Cat\# C01010130, Liège, Belgium) and from the other seven tissues following the iDeal ChIP-Seq Kit for histones (Diagenode, Cat\# C01010059, Liège, Belgium) with the modifications or specifications described in this paper. The starting amount varied depending on tissue, such that those with extensive extracellular matrices and/or low ratio of nuclei to cellular matter required larger amounts of starting material compared to those tissues that homogenized easily. Samples were homogenized either by douncing (liver) or grinding with the Tissue Lyser II (Qiagen, Germany) at 25 strokes/minute for a length of time that varied by tissue ([Table 1](#genes-11-00003-t001){ref-type="table"}).

In order to reach the desired fragment length (approximately 200 bp), chromatin was sheared with the Bioruptor Pico (Diagenode, Cat\# B01060001, Liège, Belgium) combined with the Bioruptor^®^ Water cooler for 8--12 cycles of 30 s with 30 s rest between cycles. The temperature was maintained at 10 °C for adipose and 4 °C for all other tissues during shearing. The number of cycles varied based on tissue ([Table 1](#genes-11-00003-t001){ref-type="table"}), and the chromatin quality was assessed using the Fragment Analyzer (Aligent, Santa Clara, CA, USA).

2.2. Immunoprecipitation {#sec2dot2-genes-11-00003}
------------------------

Immunoprecipitation (IP) of the four histone marks, along with a negative IP control (IgG), was performed on tissue-specific amounts of chromatin using the IP-Star Compact Automated System (Diagenode, Cat\# B03000002, Liège, Belgium). The antibodies used were all previously validated by Diagenode, and antibody concentrations were determined during QC for every tissue and histone mark combination ([Table S1](#app1-genes-11-00003){ref-type="app"}). An aliquot of chromatin from each tissue was set aside for the input to characterize sequencing background and identify true ChIP enrichment.

2.3. Sequencing {#sec2dot3-genes-11-00003}
---------------

Libraries were prepared using the IP-Star^®^ Compact Automated System (Diagenode, Cat\# B03000002, Liège, Belgium) and the MicroPlex Library Preparation Kit v2 (Diagenode, Cat\# C05010013, Liège, Belgium) for the input and four ChIPs per tissue. Libraries were amplified prior to sequencing for at least 10 cycles, and additional cycles were performed as needed to reach a concentration of 3--10 nM. Using Agencourt AMPure XP (Bechman Coulter, Brea, CA, USA), libraries were purified and fragments were size-selected for approximately 200 bp. Libraries were sequenced as 50 bp, single-end reads on the HiSeq 4000 platform (Illumina, San Diego, CA, USA) to generate approximately 55--80 M raw reads for H3K27me3 and 30--50 M raw reads for the other marks and inputs.

2.4. Data Processing {#sec2dot4-genes-11-00003}
--------------------

A complete summary of the bioinformatic workflow can be accessed at <ftp://ftp.faang.ebi.ac.uk/ftp/protocols/analysis/>, and bioinformatic parameters that varied by mark are summarized in [Table 2](#genes-11-00003-t002){ref-type="table"}. Reads were trimmed using Trim-Galore version 0.4.0 \[[@B29-genes-11-00003],[@B30-genes-11-00003]\] under the default parameters and aligned to EquCab3.0 \[[@B31-genes-11-00003]\] with BWA-MEM version 0.7.9a \[[@B32-genes-11-00003]\], such that split hits were marked as secondary alignments. Alignments were converted to BAM file format, processed, and filtered using SAMtools version 1.9 \[[@B33-genes-11-00003]\]. For strict quality filtering, reads were removed if they did not map, had secondary alignments, failed platform/vendor quality tests, were identified as optical duplicates, or had an alignment quality score lower than 30. PCR duplicates were marked with PicardTools version 2.7.1 \[[@B34-genes-11-00003]\] and then removed with SAMtools. For peak-calling, MACS2 version 2.1.1.20160309 \[[@B35-genes-11-00003]\] was used to call peaks for all marks, and SICERpy version 0.1.1 \[[@B36-genes-11-00003]\], which is a wrapper for executing SICER \[[@B37-genes-11-00003]\], was also used to call peaks for the broad mark, H3K27me3. Combining peak-calls involved identifying overlapping regions of enrichment in both biological replicates where at least one replicate was significantly enriched based on a set of significance thresholds that varied by mark ([Table 2](#genes-11-00003-t002){ref-type="table"}). Additionally, enrichment tracks (bigWig files) were generated using deepTools version 2.4.3, which subtracted background characterized by the input and then combined enrichment from both replicates.

2.5. Data Analysis {#sec2dot5-genes-11-00003}
------------------

As with the QC data, the datasets from the eight TOI were assessed by calculating library complexity and ChIP enrichment metrics, as well as evaluating the genomic distribution of detected marks. Identity between peaks called for ECA_UCD_AH1 and ECA_UCD_AH2 were compared to assess the similarity of the biological replicates using the Jaccard Index \[[@B38-genes-11-00003]\], also known as the Jaccard Similarity Coefficient, from BEDtools version 2.27.1 \[[@B39-genes-11-00003]\]. Unique peaks were defined as a peak for a given mark that does not have any overlap with peaks from the same mark in the other prioritized tissues. BEDtools version 2.27.1 was used to identify unique peaks, as well as calculate the percent of the genome covered by peaks. Graphs were generated using ggplot2 with R software version 3.4.3 \[[@B40-genes-11-00003],[@B41-genes-11-00003]\]. To characterize the average peak topology in relation to gene annotations and calculate normalized enrichment patterns, we used deepTools version 2.4.3. RNA-Seq data from the two FAANG replicates allowed for site-specific validation of the histone peaks (ERR2584116, ERR2584168, ERR2584153, ERR2584205, ERR2584194, ERR2584142, ERR2584135, ERR2584187, ERR2584195, ERR2584143, ERR2584197, ERR2584145, ERR2584144, ERR2584196, ERR2584152, and ERR2584204). Analysis of Motif Enrichment (AME) from the MEME Suite version 5.0.5 \[[@B42-genes-11-00003]\] was used to identify known transcription factor binding motifs within peaks based on the JASPAR 2018 vertebrate database \[[@B43-genes-11-00003]\], and Biological Process Gene Ontologies (GOs) from Swiss Prot were used to perform a GO term analysis \[[@B44-genes-11-00003]\]. Novel motifs were characterized with DREME and MEME, and each of the novel motifs was manually investigated to identify additional known motifs that were not included in the JASPAR database. The Integrated Genome Viewer \[[@B45-genes-11-00003]\] was used to visualize peak-calls in conjunction with the Ensembl annotation (release 95) for the EquCab3.0 reference assembly \[[@B46-genes-11-00003]\]. String version 11.0 was used to perform a protein--protein interaction analysis on the transcription factors implicated in each tissue based on the enriched motifs identified in the tissue-specific active enhancer elements \[[@B47-genes-11-00003]\].

3. Results {#sec3-genes-11-00003}
==========

Quality control testing was performed to determine tissue-specific laboratory parameters such as antibody concentration and shearing time ([Table 1](#genes-11-00003-t001){ref-type="table"} and [Table S1](#app1-genes-11-00003){ref-type="app"}) by comparing the quality metrics and peak-calls to ENCODE and FAANG standards ([Table S2](#app1-genes-11-00003){ref-type="app"}). The raw and processed data are available on <https://data.faang.org/home> under the study accession PRJEB35307. The processed files include read alignments to EquCab3.0 and peak-calls for each biological replicate, as well as the combined peak-calls.

3.1. Assessing Data Quality {#sec3dot1-genes-11-00003}
---------------------------

Using the Jaccard Index to compare replicates for all of the marks, we found the highest identity between the two replicates of the same tissue ([Figure 1](#genes-11-00003-f001){ref-type="fig"}), with the exception of the brain replicates for H3K4me1 and the ovary replicates for H3K27me3. For the brain replicates, ECA_UCD_AH2 had 65,327 peaks compared to 143,328 peaks for ECA_UCD_AH1 ([Table 3](#genes-11-00003-t003){ref-type="table"}). In addition to a lower peak number, two of the library complexity quality scores for the ECA_UCD_AH2 brain replicate were lower than the ENCODE quality thresholds ([Table 4](#genes-11-00003-t004){ref-type="table"}). In terms of enrichment, however, the cross-correlation metrics for this sample were both above the established thresholds and indicate that the data had sufficient ChIP enrichment. Indeed, we were able to call 95,918 combined peaks, which is consistent with the range of H3K4me1 values from the other tissues. For the ovary replicates, two of the three library complexity metrics were below ENCODE standards, yet all of the ChIP enrichment metrics were consistent with those for the broad mark in other tissues, indicating that we had sufficient ChIP enrichment despite lower library complexity. When comparing SICER and MACS2 peak-calls for the broad mark, the number of combined peaks (8479 and 40,825, respectively) and the percentage of the genome covered (2.1% and 1.2%, respectively) for ovary were all consistent with the same measures for the H3K27me3 peaks from the other tissues evaluated in this study.

While demonstrating more variation than the other marks, H3K27me3 had peaks called by SICER that were more similar between replicates of the same tissue compared to the H3K27me3 peaks called by MACS2 software ([Figure S1](#app1-genes-11-00003){ref-type="app"}). Peak-calls from the two biological replicates were combined by identifying regions of overlapping enrichment in which at least one replicate had significant enrichment based on a q-value that differed by mark ([Table 2](#genes-11-00003-t002){ref-type="table"}). For H3K4me1, H3K4me3, and H3K27ac, the number of combined peaks ranged from 93--121 K, 26--29 K, and 64--88 K, respectively. The number of combined peaks called for the broad mark was lower than the three activating marks for both MACS2 and SICER (24--68 K and 7--11 K, respectively). Although the combined peak numbers for the MACS2-H3K27me3 datasets were more similar to the ENCODE equivalent than the number of peaks called by SICER ([Table S3](#app1-genes-11-00003){ref-type="app"}), the SICER-H3K27me3 combined peaks covered a larger portion of the genome, similar to that for the other marks ([Table 3](#genes-11-00003-t003){ref-type="table"}). Files for H3K27me3 peaks called by MACS2 and SICER are both publicly available for every tissue.

As a proof-of-principle, we investigated a small number of regions near well-characterized genes to compare the histone peaks with RNA-seq data generated from the same tissues. We found consistent activating marks across all tissues for a widely expressed gene, *ACTB* ([Figure 2](#genes-11-00003-f002){ref-type="fig"}A). Conversely, liver was the only tissue enriched for a set of active histone marks near the transcription start site (TSS) of the liver-specific gene *CYP2E1* ([Figure 2](#genes-11-00003-f002){ref-type="fig"}B) \[[@B48-genes-11-00003]\].

3.2. Characterizing Tissue-Specific Features {#sec3dot2-genes-11-00003}
--------------------------------------------

Brain tissue had the highest percentage of unique peaks, defined as peaks that were only found in that tissue, for H3K27ac (31%) and H3K27me3 (20%), while liver had the highest percentage of unique peaks for H3K4me1 (32%) and H3K4me3 (16%), along with the second highest for H3K27ac (26%) and H3K27me3 (14%) ([Figure 3](#genes-11-00003-f003){ref-type="fig"}). Lamina tissue also had a high percentage of unique peaks for the three activating marks with 24, 10, and 26% for H3K4me1, H3K4me3, and H3K27ac, respectively.

In addition to characterized genes, we also investigated a small number of genomic regions with putative tissue-specific functions in liver and muscle. For liver, a potential tissue-specific regulatory element was identified in the 59th intron of *PKHD1* (Ensembl Transcript ID: ENSECAT00000024985.1; [Figure 4](#genes-11-00003-f004){ref-type="fig"}), a gene which has been previously associated with liver fibrosis \[[@B49-genes-11-00003]\]. Similarly, when considering a genomic region associated with racing ability \[[@B50-genes-11-00003]\], peaks for H3K4me3 in both muscle tissues were discovered at the start of a predicted lncRNA from Ensembl genebuild \[[@B51-genes-11-00003]\], indicating that this uncharacterized gene may be particularly informative for the function of contractile tissue ([Figure 5](#genes-11-00003-f005){ref-type="fig"}).

Across all tissues, H3K4me1 was enriched around the TSS, with a decrease in enrichment at the actual annotated start site that created a bimodal distribution across the average gene body ([Figure 6](#genes-11-00003-f006){ref-type="fig"}A). Additionally, H3K4me1 maintained a moderate level of enrichment throughout the gene body, as well as 3 Kb up- and downstream, as expected for distal and proximal enhancer elements. Alternatively, H3K4me3 ([Figure 6](#genes-11-00003-f006){ref-type="fig"}B) and H3K27ac ([Figure 6](#genes-11-00003-f006){ref-type="fig"}C) had peaks of enrichment at the TSS, although H3K27ac also showed enrichment, to a lesser extent, just upstream of the TSS. H3K27me3 had lower enrichment than the other three marks overall, but the average enrichment was essentially constant throughout the gene body, as well as 3 Kb up- and downstream ([Figure 6](#genes-11-00003-f006){ref-type="fig"}D). While patterns of enrichment for each mark were highly consistent between tissues, the enrichment of H3K27me3 for lamina was lower at the TSS compared to the other tissues.

3.3. Identifying Motifs and Biological Process GO Terms {#sec3dot3-genes-11-00003}
-------------------------------------------------------

We identified between 16 and 61 transcription factor binding motifs in the unique active regions for each tissue, and the full results from the GO term analysis can be found in [Tables S4--S19](#app1-genes-11-00003){ref-type="app"}. While a large proportion of the identified transcription factors were still shared between tissues despite being identified in tissue-specific active regions, all of the tissues except for adipose and lung had at least one uniquely detected transcription factor binding site. A uniquely detected binding site was defined as a motif that was only identified in the tissue-specific active regions for a single tissue. The motifs were ranked based on significance of enrichment after multiple testing correction, and the top five enriched and identified motifs for each tissue are listed in [Table 5](#genes-11-00003-t005){ref-type="table"}. Ovary was the only tissue that had uniquely detected transcription factor motifs in this top five list, and the most significant motif was associated with FOXO3, which is a transcription factor (TF) characterized by 39 GO terms, including several for tissue-specific functions such as oocyte maturation (GO:0001556) and ovulation (GO:0001542). In fact, upon closer inspection, the FOXO3 motif was found within a tissue-specific regulatory element near a gene with recognized roles in mammalian reproduction, *NR5A1* ([Figure 7](#genes-11-00003-f007){ref-type="fig"}) \[[@B52-genes-11-00003]\]. Using a network analysis for TFs implicated in each tissue, we found that six networks contained EP300 as a central node, although these networks did not link every TF for a given tissue ([Figure 8](#genes-11-00003-f008){ref-type="fig"}A). Interestingly, MYC was the central node for brain, liver, and skeletal muscle ([Figure 8](#genes-11-00003-f008){ref-type="fig"}B), and TP53 was the central node for lung ([Figure 8](#genes-11-00003-f008){ref-type="fig"}C).

4. Discussion {#sec4-genes-11-00003}
=============

As part of the FAANG consortium, we mapped more than 1 million putative regulatory sites across the equine genome, which will contribute significantly to our understanding of genome regulation in horses, as well as regulatory differences across species. To ensure that we obtained high quality data for the horse, we first performed QC experiments to optimize tissue-specific laboratory protocols ([Table S2](#app1-genes-11-00003){ref-type="app"}). Adipose tissue presented a distinct challenge for chromatin extraction due to the low number of nuclei and large amount of cellular material, including lipid deposits. Efforts to obtain high quality data were successful, as quality metrics for this tissue surpassed ENCODE standards or scored within the range of the other tissues for a given mark. From this work, we suspect that other difficult tissues (i.e., those with low nuclei density, extensive and persistent extra- or intracellular material, etc.) will also require similar alternate approaches for chromatin extraction, such as additional starting material or specialized kits.

To ensure accurate and relevant peak-calling, we employed MACS2 software for calling H3K4me1, H3K4me3, and H3K27ac peaks and both MACS2 and SICER for H3K27me3 peaks. While several attempts have been made to develop a bench-marking method for ranking ChIP peak-callers, there is no established gold standard for selecting a particular application \[[@B53-genes-11-00003]\]. Steinhauser et al., for example, found that SICER was better able to detect true-positive differential regions (DRs) when H3K36me3 data were down-sampled to as low as 10%, while MACS2 was only effective at detecting true-positive DRs at 60% or higher \[[@B54-genes-11-00003]\]. SICER, however, had a higher number of false-positive DRs compared to MACS2, indicating that it may be sacrificing some specificity to obtain higher sensitivity, while MACS2 does the opposite. Based upon generating peaks with higher identity between replicates ([Figure S1](#app1-genes-11-00003){ref-type="app"}) and higher proportions of the genome covered ([Table 3](#genes-11-00003-t003){ref-type="table"}), we found SICER software to be more consistent for calling broad peak-calls compared to MACS2, which is consistent with previous research \[[@B55-genes-11-00003]\]. For that reason, we continued our investigations using the SICER-called H3K27me3 peaks. Given that peaks from both callers are supported in the literature for other species studied, both sets of peak-calls are available at <https://data.faang.org/dataset/PRJEB35307>.

Using the Jaccard Similarity Index to compare significant peak-calls, we determined that biological replicates were highly similar for each tissue with the exception of the brain replicates for H3K4me1 and the ovary replicates for H3K27me3 ([Figure 1](#genes-11-00003-f001){ref-type="fig"}). While these low identity scores could be the result of underlying biological differences between the samples of brain or ovary tissue, this is unlikely given that the differences between replicates were only found in one mark for each of the two tissues. Using a bioinformatic method that relied on identifying overlapping enrichment rather than the intersection of significant peaks ensured accurate combined peak calling despite lower similarity scores. Combined peak-calls were assessed for significant enrichment surrounding genes with known expression patterns. In particular, the three active marks (H3K4me1, H3K4me3, and H3K27ac) had consistent peaks between tissues near *ACTB* ([Figure 2](#genes-11-00003-f002){ref-type="fig"}A) and tissue-specific peaks near the liver enzyme *CYP2E1* ([Figure 2](#genes-11-00003-f002){ref-type="fig"}B), which support the validity of our peak-calling methods. Additionally, these peak-calls were all consistent with RNA expression from the same tissues for ECA_UCD_AH1 and ECA_UCD_AH2, further supporting the validity of the enrichment patterns detected for each histone mark.

Comparing replicated peaks between tissues, we found that liver, brain, and lamina had the highest percentage of peaks that were unique to only that tissue ([Figure 3](#genes-11-00003-f003){ref-type="fig"}). Liver is known to have hundreds of distinct biological functions \[[@B48-genes-11-00003]\]. Since many of the functions are entirely unique to liver, a high proportion of unique active regulatory elements is consistent with the specialization of this tissue. Additionally, the mammalian brain is thought to have hundreds of different neuronal cell types within the cortex to coordinate numerous neurologic functions simultaneously, making it one of the most complex tissues of the body \[[@B56-genes-11-00003]\]. Therefore, these results are consistent with the expectation that there is a high degree of regulatory specificity to control numerous coordinated functions within complex tissues.

Interestingly, lamina was the other tissue with a high percentage of unique peaks for H3K4me1, H3K4me3, and H3K27ac ([Figure 3](#genes-11-00003-f003){ref-type="fig"}). Due to the role of lamina in disease, this finding may be particularly impactful for research into the physiological changes associated with laminitis, a syndrome that was established as a priority for equine research by the American Association of Equine Practitioners \[[@B57-genes-11-00003],[@B58-genes-11-00003]\]. Additionally, when comparing the distribution of marks across the average gene body, we found that lamina tissue had an unusually low level of the repressive mark, H3K27me3, at the TSS ([Figure 6](#genes-11-00003-f006){ref-type="fig"}). While all of the tissues had a portion of genes that appear to have a dip in enrichment directly at the TSS, lamina had the most extreme decrease. Perhaps the dip in enrichment for lamina is an indication of increased levels of expression across more of the genome and, when combined with the high percentage of unique peaks, could suggest that hoof lamina may perform additional biological processes that are currently uncharacterized. In order to understand all of the molecular functions of lamina tissue and its role in laminitis, more work is needed to further annotate and functionally characterize the extent of the cellular processes within healthy and diseased tissue. Without further validation, however, we cannot exclude that this decrease in enrichment may be a technical artifact such as decreased detection of H3K27me3 in lamina tissue due to low cell numbers and excess extracellular matrix.

To further characterize tissue-specific regulatory regions, we identified numerous transcription factor binding motifs within the unique active elements for each tissue ([Table 5](#genes-11-00003-t005){ref-type="table"}). Despite investigating elements that were only enriched in one tissue, we still identified many transcription factor motifs that were shared between tissues ([Table 4](#genes-11-00003-t004){ref-type="table"} and [Table S19](#app1-genes-11-00003){ref-type="app"}) and, based on a GO term analysis, many of these factors had numerous associated biological processes ([Tables S4--S18](#app1-genes-11-00003){ref-type="app"}). Our network analysis identified EP300 as a central secondary factor needed to connect many implicated TFs ([Figure 8](#genes-11-00003-f008){ref-type="fig"}A). This gene encodes a histone acetyltransferase that is known to interact with many TFs by protein--protein interactions rather than DNA binding \[[@B59-genes-11-00003],[@B60-genes-11-00003]\]. Given that the TF motifs were all identified within active elements based on the presence of H3K27ac, finding a connection with EP300 supports our ability to detect relevant peaks for this histone modification. Interestingly, there were three tissues (brain, liver, and muscle) that had MYC rather than EP300 as the central node for their TF networks ([Figure 8](#genes-11-00003-f008){ref-type="fig"}B). We found that binding motifs for MYC were enriched in all three tissues, which is consistent with its role as a TF for many common cellular processes, including growth and regulation of the cell cycle \[[@B61-genes-11-00003]\]. Similarly, TP53 was the central node in the protein interaction network for lung tissue ([Figure 8](#genes-11-00003-f008){ref-type="fig"}C), which is consistent with its role as a key regulator of the cell cycle when functional and as a major tumorigenesis factor in lung cancer when dysfunctional \[[@B62-genes-11-00003]\].

By developing tissue-specific maps of the H3K4me1, H3K4me3, H3K27ac, and H3K27me3 histone modifications, we aimed to build upon our current knowledge about genomic regulation in the horse and provide new resources for further advancing research on health, performance, and reproduction traits. In particular, incorporating histone ChIP-seq data with current annotations is expected to lead to the discovery of more tissue-specific functional variants that are outside of protein-coding regions. For example, a genome-wide investigation of liver fibrosis in the Swiss Franches-Montagnes breed led to the identification of an associated region containing a promising candidate gene, *PKHD1*, which was also associated with kidney and liver disease in humans \[[@B49-genes-11-00003]\]. Sequencing the coding region of this gene identified two synonymous coding variants strongly associated with disease; however, their causal role remains unclear. Comparing peaks from multiple tissues in that region, there are also several liver-specific regulatory peaks within intron 59 of *PKHD1* (Ensembl Transcript ID: ENSECAT00000024985.1) that may affect expression of this or another hepatic gene nearby ([Figure 4](#genes-11-00003-f004){ref-type="fig"}) and represent another avenue to explore for the molecular mechanism underlying liver fibrosis.

Tissue-specific histone modifications have also been implicated in the complex traits of performance \[[@B63-genes-11-00003]\] and, throughout modern horse domestication, performance abilities such as speed have been a major factor for selective breeding \[[@B64-genes-11-00003]\]. For example, recent research comparing three trotting breeds in Scandinavia (North Swedish Draught, Norwegian--Swedish Coldblooded trotter, and Standardbred trotter) found a 684 Kb genomic region associated with trotting racing ability containing numerous annotated and unannotated genes \[[@B50-genes-11-00003]\]. Using a protein-coding annotation, only one gene in the region, *TRIM37*, was identified as a potential candidate due to its associations with growth phenotypes in humans. Utilizing the locations of histone mark enrichment could help to identify other candidates such as tissue-specific regulatory regions or the genes that they regulate. In particular, there are H3K4me3 peaks at the start of a novel lncRNA predicted by Ensembl genebuild \[[@B51-genes-11-00003]\] within the region of interest for racing ability ([Figure 5](#genes-11-00003-f005){ref-type="fig"}A). While uncharacterized, *LOC111775680* has a set of unique promoters found in skeletal and cardiac muscle with corresponding transcript data (as determined by RNAseq of the same tissues from ECA_UCD_AH1 and ECA_UCD_AH2), suggesting that the lncRNA may play a role in muscle physiology ([Figure 5](#genes-11-00003-f005){ref-type="fig"}B). Additional work is needed to further characterize *LOC111775680* and investigate its potential role in muscle tissue and any corresponding effects on racing ability.

In addition to health and performance, these annotation data can also be used to identify important genomic regulatory regions for the reproductive system. Previously, homology with humans and mice was utilized to create a panel of candidate regions for determining the genetic cause of gonadal dysgenesis disorders across many breeds of horses \[[@B65-genes-11-00003]\], yet the panel was focused on coding variants and those within untranslated regions that may affect RNA and protein synthesis. By evaluating histone marks, we found that there are additional regulatory regions relevant to the reproductive system that were missed by the homology-based approaches. For example, *NR5A1*, a gene that is implicated in many dysgenesis cases \[[@B52-genes-11-00003],[@B66-genes-11-00003]\], has a regulatory region as identified by H3K4me1 and H3K27ac histone modifications in equine ovary tissue that is characteristic of an active enhancer ([Figure 7](#genes-11-00003-f007){ref-type="fig"}A). Upon further inspection, we identified two FOXO3 binding sites within the region enriched with peak-calls ([Figure 7](#genes-11-00003-f007){ref-type="fig"}B,C). FOXO3 is a transcription factor with known roles in oocyte maturation \[GO:0001556\] and ovulation \[GO:0001542\] that was identified as an ovary-specific TF based on our motif analysis ([Table S18](#app1-genes-11-00003){ref-type="app"}).

Along with the regulatory regions identified in this study, the equine FAANG consortium is characterizing the full RNA profile of more than 50 tissues and cell types from the FAANG equine biobank supported by a research community initiative \[[@B26-genes-11-00003]\] and the DNA methylation profiles for the TOI. Moreover, the equine FAANG consortium is currently mapping a major insulator protein known as CTCF, with the goal of generating tissue-specific chromatin state predictions for the eight TOI. CTCF plays a key role in defining chromatin looping and, therefore, topologically associated domains and gene-enhancer interactions when combined with histone ChIP-Seq \[[@B67-genes-11-00003],[@B68-genes-11-00003]\]. The same panel of genomic investigations are also being conducted in two stallions, so that males and females are represented in the annotations. We anticipate that the integration and utilization of these functional annotation datasets by the equine genomics community will lead to the identification of causal, non-coding variants underlying many traits of interest for equine medicine, performance, and reproduction.

The authors would like to acknowledge members of the UC Davis FAANG group for providing their technical expertise and feedback. The authors would also like to acknowledge the contributions from horse owners that made this work possible.
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![Jaccard Index to measure similarity of peaks called for each histone mark and tissue between biological replicates, ECA_UCD_AH1 and ECA_UCD_AH2. Each panel is a heatmap displaying the Jaccard Index for pairwise comparisons of tissues between replicates. Darker purple indicates that there are more peaks that are shared by the two tissues. (**A**) H3K4me1, (**B**) H3K4me3, (**C**) H3K27ac, (**D**) H3K27me3 called by SICER.](genes-11-00003-g001){#genes-11-00003-f001}

![Proof-of-principle investigating house-keeping gene, *ACTB*, and liver-specific gene, *CYP2E1*, for appropriate regulatory elements. For adipose, brain, and liver tissue, combined peaks are displayed for H3K4me1 (aqua), H3K4me3 (light blue), H3K27ac (dark blue), H3K27me3 from SICER (orange), and mRNA expression (purple). (**A**) *ACTB* is a housekeeping gene that is commonly expressed for many tissues. (**B**) *CYP2E1* is a liver enzyme, which displays tissue-specific expression. Note the presence of the H3K27me3 repressive mark (orange) within adipose and brain samples.](genes-11-00003-g002){#genes-11-00003-f002}

![Tissue-specific peaks for each histone mark. Grey area indicates the number of peaks for a particular histone tail modification that are shared between at least two tissues, while the color region of each bar indicates the number of tissue-specific peaks. Percentage values are also assigned to the two segments of each bar to indicate the proportion of shared and unique peaks. (**A**) H3K4me1, (**B**) H3K4me3, (**C**) H3K27ac, (**D**) H3K27me3 from SICER.](genes-11-00003-g003){#genes-11-00003-f003}

![Evidence of a tissue-specific regulatory element found in liver tissue. For each tissue, peaks are displayed for H3K4me1 (aqua), H3K4me3 (light blue), H3K27ac (dark blue), and H3K27me3 from SICER (orange). (**A**) Gold box highlights liver-specific active marks in the 59th intron of an annotated gene, *PKHD1* (Ensembl Transcript ID: ENSECAT00000024985.1), which is transcribed from the antisense strand. H3K4me1 marks were also detected in ovary tissue at the end of the gene, but they do not indicate the presence of an active enhancer without co-occurrence of H3K27ac. (**B**) Enrichment profiles (BigWig) were visualized below the corresponding peak tracks for the region highlighted by the gold box in A.](genes-11-00003-g004){#genes-11-00003-f004}

![Visualizing tissue-specific peak-calls using the Integrated Genome Viewer. For each tissue, peaks are displayed for H3K4me1 (aqua), H3K4me3 (light blue), H3K27ac (dark blue), and H3K27me3 from SICER (orange). Gold boxes highlight active marks associated with promoters (H3K4me3) in both muscle tissues (skeletal and cardiac) for an unannotated ncRNA, *LOC111775680* (*ENSECAT00000049354*), and red box highlights an H3K4me3 peak specific to ovary tissue. (**B**) Zoomed in view of (**A**) for relevant tissues with RNA expression shown in purple. While ovary also appears to have a peak in H3K4me3 nearby, it does not have expression of the lncRNA based on mRNA expression from these tissue samples.](genes-11-00003-g005){#genes-11-00003-f005}

![Histone mark enrichment across the average annotated gene body. (**A**) H3K4me1, (**B**) H3K4me3, (**C**) H3K27ac, (**D**) H3K27me3 from SICER. Topology plots (top) and heat maps (bottom) show average enrichment of each histone mark in each tissue across a size-normalized gene distribution based on the Ensembl (Release 95) annotation for EquCab3.0. Each line in the heatmap represents mark enrichment across a given gene, such that red indicates low relative enrichment and blue indicates high relative enrichment.](genes-11-00003-g006){#genes-11-00003-f006}

![Localizing enriched TF binding motifs within tissue-specific peaks. For each tissue, peaks are displayed for H3K4me1 (aqua), H3K4me3 (light blue), H3K27ac (dark blue), and H3K27me3 from SICER (orange). Gold box highlights ovary specific marks in intron of *NR5A*. (**B**) Motif logo displays one of the major motifs for FOXO3. (**C**) Zoomed in view of 40 bp within region highlighted in (**A**). The gold track indicates the presence of two nearly consecutive motifs for FOXO3 within the H3K4me1 and H3K27ac peaks that were detected only in ovary tissue.](genes-11-00003-g007){#genes-11-00003-f007}

![Network of transcription factor interactions based on active motif regions in ovary, skeletal muscle, and lung tissues. Each circle represents a protein, and lines indicate interactions between proteins. Each line color indicates a different type of evidence for the interaction. Protein names highlighted in grey were not identified in the horse ChIP-seq data but were identified as secondary factors by the network analysis based on implicated or known protein--protein interactions from research in humans and mice. (**A**) EP300 is highlighted in gold to denote its central role in the network for ovary tissue. (**B**) MYC is highlighted in gold to indicate its central role in the network for muscle tissue. (**C**) TP53 is highlighted in gold to indicate its central role in the network for lung. Legend is from String Software \[[@B47-genes-11-00003]\].](genes-11-00003-g008){#genes-11-00003-f008}
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###### 

Optimized ChIP-Seq experimental procedures for each tissue.

  Parameter                   Adipose     Brain   Heart   Lamina   Liver   Lung   Muscle   Ovary
  --------------------------- ----------- ------- ------- -------- ------- ------ -------- -------
  Starting Tissue (mg)        220         90      105     100      40      40     100      85
  Homogenization Time (min)   8           5       5       9        n/a     5      5        5
  Duration Fixed (min)        10          9       9       9        9       9      9        9
  Fixation Temp. (°C)         37          23      23      23       23      23     23       23
  Shearing Volume (uL)        400         1500    1800    1800     1500    1500   1800     1800
  Shearing Cycles             5 × 8 ^1^   10      13      10       12      10     12       10
  Chromatin per IP (ng)       700         300     500     700      450     800    260      1200

^1^ Samples were sonicated for five sets of eight cycles.
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###### 

Software parameters used to analyze ChIP-Seq data for each histone mark.

  Software          Parameter        H3K4me1          H3K4me3          H3K27ac          H3K27me3
  ----------------- ---------------- ---------------- ---------------- ---------------- ----------
  **MACS2**         Filtering        strict           strict           strict           strict
  Size              narrow ^1^       narrow           narrow           broad            
  Size Flag         none             none             none             \--broad         
  Model             \--fix-bimodal   \--fix-bimodal   \--fix-bimodal   \--fix-bimodal   
  Genome Size       2,409,143,234    2,409,143,234    2,409,143,234    2,409,143,234    
  **both**          Fragment Size    200              200              200              200
  FDR               0.05             0.01             0.01             0.1              
  **SICERpy ^2^**   Gap Size         n/a              n/a              n/a              4
  Window Size       n/a              n/a              n/a              200              
  Genome Fraction   n/a              n/a              n/a              0.63             

^1^ Mark was treated as broader than other narrow marks due to being categorized previously as broad by ENCODE \[[@B19-genes-11-00003]\]. ^2^ SICERpy was only used to call peaks for the broad mark, H3K27me3.
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###### 

Summary of peak number and percent of the genome covered for each mark and tissue.

  Mark           Tissue    Software   Combined Peak Number   Percent Genome Covered   AH1 Peak Number   AH2 Peak Number
  -------------- --------- ---------- ---------------------- ------------------------ ----------------- -----------------
  **H3K4me1**    Adipose   MACS2      107,318                5.1                      130,242           157,497
  Brain          MACS2     95,918     3.1                    143,328                  65,327            
  Heart          MACS2     121,663    4.9                    137,385                  155,881           
  Lamina         MACS2     114,708    4.2                    137,575                  124,150           
  Liver          MACS2     116,760    3.6                    97,863                   135,122           
  Lung           MACS2     92,972     2.9                    90,687                   109,001           
  Muscle         MACS2     95,816     3.7                    137,322                  100,999           
  Ovary          MACS2     102,986    4.3                    166,303                  133,209           
  **H3K4me3**    Adipose   MACS2      26,905                 1.7                      26,286            29,121
  Brain          MACS2     27,101     1.6                    25,473                   28,028            
  Heart          MACS2     26,475     1.4                    24,101                   27,985            
  Lamina         MACS2     29,380     1.6                    29,023                   19,742            
  Liver          MACS2     28,498     1.5                    28,204                   28,222            
  Lung           MACS2     28,546     1.6                    30,048                   27,779            
  Muscle         MACS2     28,110     1.6                    30,428                   25,123            
  Ovary          MACS2     28,378     1.7                    30,522                   29,192            
  **H3K27ac**    Adipose   MACS2      79,620                 3.3                      75,823            99,249
  Brain          MACS2     78,823     3.2                    89,445                   73,795            
  Heart          MACS2     68,728     2.9                    71,462                   7192              
  Lamina         MACS2     82,394     2.9                    91,345                   78,953            
  Liver          MACS2     87,589     3.1                    84,814                   96,238            
  Lung           MACS2     69,054     2.9                    69,621                   75,299            
  Muscle         MACS2     76,495     2.9                    78,047                   86,524            
  Ovary          MACS2     64,318     3.3                    94,817                   82,318            
  **H3K27me3**   Adipose   MACS2      25,183                 0.6                      8948              29,906
  Brain          MACS2     24,243     0.6                    16,055                   23,411            
  Heart          MACS2     68,113     1.8                    31,455                   88,818            
  Lamina         MACS2     37,366     0.8                    31,839                   28,508            
  Liver          MACS2     63,874     1.3                    93,423                   23,888            
  Lung           MACS2     30,191     0.7                    32,385                   18,124            
  Muscle         MACS2     42,610     0.9                    39,076                   29,579            
  Ovary          MACS2     40,825     1.2                    43,036                   33,220            
  **H3K27me3**   Adipose   SICER      8167                   4.9                      13,540            14,571
  Brain          SICER     7860       3.4                    11,386                   13,603            
  Heart          SICER     9032       3.3                    12,192                   18,903            
  Lamina         SICER     7072       3.8                    11,933                   11,694            
  Liver          SICER     11,430     3.7                    22,270                   16,099            
  Lung           SICER     7863       2.6                    12,668                   11,715            
  Muscle         SICER     8437       4.6                    17,073                   10,987            
  Ovary          SICER     7083       3.0                    14,731                   11,124            
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###### 

Quality metrics for assessing library complexity and ChIP enrichment. Thresholds for NRF, PBC1, PBC2, NSC, and RSC represent those developed by the Encyclopedia of DNA Elements (ENCODE) \[[@B27-genes-11-00003]\]. JSD threshold was established among members of the Functional Annotation of ANimal Genomes (FAANG) consortium.

  Mark           Tissue    Rep     NRF     PBC1    PBC2    NSC     RSC     JSD
  -------------- --------- ------- ------- ------- ------- ------- ------- -------
  **H3K4me1**    Adipose   AH2     0.677   0.673   3.017   1.068   1.249   0.281
  Adipose        AH1       0.621   0.617   2.595   1.067   1.147   0.239   
  Brain          AH2       0.435   0.443   1.908   1.055   1.243   0.186   
  Brain          AH1       0.754   0.756   4.128   1.074   1.275   0.228   
  Heart          AH2       0.708   0.708   3.444   1.086   1.790   0.321   
  Heart          AH1       0.497   0.496   2.023   1.071   1.657   0.259   
  Lamina         AH2       0.606   0.606   2.551   1.093   1.628   0.281   
  Lamina         AH1       0.561   0.562   2.311   1.088   1.809   0.283   
  Liver          AH2       0.760   0.762   4.226   1.097   1.240   0.226   
  Liver          AH1       0.838   0.842   6.462   1.117   1.289   0.252   
  Lung           AH2       0.736   0.736   3.796   1.079   1.123   0.199   
  Lung           AH1       0.667   0.665   2.980   1.069   1.063   0.178   
  Muscle         AH2       0.706   0.706   3.418   1.077   1.030   0.210   
  Muscle         AH1       0.576   0.573   2.338   1.084   1.200   0.259   
  Ovary          AH2       0.712   0.712   3.488   1.077   1.265   0.245   
  Ovary          AH1       0.692   0.691   3.240   1.085   2.117   0.313   
  **H3K4me3**    Adipose   AH2     0.595   0.604   2.581   1.322   1.391   0.382
  Adipose        AH1       0.559   0.571   2.389   1.313   1.501   0.354   
  Brain          AH2       0.497   0.515   2.167   1.366   1.198   0.516   
  Brain          AH1       0.333   0.362   1.813   1.360   1.249   0.528   
  Heart          AH2       0.410   0.435   1.905   1.467   1.364   0.540   
  Heart          AH1       0.337   0.374   1.857   1.399   1.639   0.548   
  Lamina         AH2       0.529   0.551   2.345   1.384   1.188   0.467   
  Lamina         AH1       0.571   0.594   2.606   1.380   1.289   0.465   
  Liver          AH2       0.452   0.471   1.996   1.407   1.196   0.517   
  Liver          AH1       0.421   0.444   1.926   1.385   1.282   0.537   
  Lung           AH2       0.610   0.628   2.813   1.354   1.154   0.387   
  Lung           AH1       0.580   0.600   2.634   1.344   1.117   0.452   
  Muscle         AH2       0.240   0.277   1.818   1.340   1.354   0.441   
  Muscle         AH1       0.559   0.567   2.350   1.350   1.164   0.448   
  Ovary          AH2       0.633   0.646   2.926   1.315   1.191   0.428   
  Ovary          AH1       0.603   0.622   2.779   1.335   1.220   0.439   
  **H3K27ac**    Adipose   AH2     0.678   0.677   3.087   1.223   1.605   0.313
  Adipose        AH1       0.537   0.532   2.129   1.250   1.800   0.333   
  Brain          AH2       0.495   0.493   2.001   1.202   1.320   0.310   
  Brain          AH1       0.655   0.657   2.939   1.200   1.341   0.326   
  Heart          AH2       0.493   0.489   1.970   1.316   2.193   0.402   
  Heart          AH1       0.573   0.573   2.361   1.331   1.856   0.376   
  Lamina         AH2       0.597   0.596   2.486   1.296   1.655   0.351   
  Lamina         AH1       0.657   0.662   3.006   1.304   1.711   0.345   
  Liver          AH2       0.719   0.722   3.651   1.258   1.225   0.347   
  Liver          AH1       0.721   0.724   3.674   1.242   1.237   0.298   
  Lung           AH2       0.500   0.499   2.008   1.241   1.290   0.327   
  Lung           AH1       0.654   0.658   2.956   1.208   1.281   0.299   
  Muscle         AH2       0.605   0.604   2.524   1.291   1.306   0.335   
  Muscle         AH1       0.510   0.511   2.072   1.285   1.335   0.381   
  Ovary          AH2       0.733   0.736   3.816   1.254   1.309   0.374   
  Ovary          AH1       0.678   0.678   3.112   1.224   1.461   0.391   
  **H3K27me3**   Adipose   AH2     0.646   0.641   2.751   1.057   0.659   0.101
  Adipose        AH1       0.650   0.647   2.809   1.053   0.592   0.067   
  Brain          AH2       0.511   0.510   2.077   1.060   0.400   0.101   
  Brain          AH1       0.616   0.614   2.587   1.067   0.477   0.088   
  Heart          AH2       0.407   0.414   1.834   1.070   0.595   0.106   
  Heart          AH1       0.287   0.315   1.778   1.090   0.649   0.102   
  Lamina         AH2       0.459   0.460   1.919   1.069   0.656   0.071   
  Lamina         AH1       0.429   0.436   1.885   1.076   0.732   0.065   
  Liver          AH2       0.545   0.537   2.140   1.076   0.648   0.093   
  Liver          AH1       0.454   0.451   1.871   1.084   0.661   0.123   
  Lung           AH2       0.619   0.615   2.575   1.072   0.617   0.072   
  Lung           AH1       0.550   0.545   2.199   1.084   0.671   0.088   
  Muscle         AH2       0.534   0.526   2.098   1.070   0.597   0.070   
  Muscle         AH1       0.476   0.472   1.914   1.079   0.689   0.103   
  Ovary          AH2       0.524   0.520   2.103   1.071   0.587   0.066   
  Ovary          AH1       0.495   0.489   1.970   1.077   0.688   0.101   
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###### 

Top five significantly enriched transcription factor binding motifs identified in tissue-specific active enhancers. Tissue specificity of the active enhancers was defined by overlap of H3K4me1 and H3K27ac in the same tissue and no overlap of these marks in this region in any other tissues, and tissue specificity of the binding motifs was then defined by detection of an enriched binding motif in only one tissue.

  Rank          Motif ID        Consensus         Adjusted *p*-Value   UniProt Entry
  ------------- --------------- ----------------- -------------------- ---------------
  **Adipose**                                                          
  1             SP3             VCCACGCCCMC       1.49 × 10^−10^       Q02447
  2             TFDP1           VSGCGGGAAVN       1.74 × 10^−10^       Q14186
  3             TFAP2A          HGCCYSAGGCD       3.27 × 10^−10^       P05549
  4             TFAP2C          YGCCYBVRGGCA      4.56 × 10^−10^       Q92754
  6             KLF16           GMCACGCCCCC       5.81 × 10^−9^        Q9BXK1
  **Brain**                                                            
  1             TFAP2A(var.2)   YGCCCBVRGGCR      1.82 × 10^−16^       P05549
  2             TFAP2B          YGCCCBVRGGCA      1.29 × 10^−13^       Q92481
  3             SP3             VCCACGCCCMC       2.69 × 10^−13^       Q02447
  4             TFAP2C          YGCCYBVRGGCA      4.99 × 10^−13^       Q92754
  5             KLF16           GMCACGCCCCC       1.06 × 10^−12^       Q9BXK1
  **Heart**                                                            
  1             MZF1            BGGGGA            2.23 × 10^−5^        P28698
  2             Ascl2           ARCAGCTGCY        7.06 × 10^−4^        Q99929
  3             ASCL1           VSAGCAGCTGSNN     9.41 × 10^−4^        P50553
  4             SP3             VCCACGCCCMC       1.42 × 10^−3^        Q02447
  5             NEUROD1         NRACAGATGGYNN     1.60 × 10^−3^        Q13562
  **Lamina**                                                           
  1             SP2             GYCCCGCCYCYBSSS   8.51 × 10^−15^       Q02086
  2             SP1             GCCCCKCCCCC       5.98 × 10^−14^       P08047
  3             SP3             VCCACGCCCMC       2.84 × 10^−13^       Q02447
  4             KLF16           GMCACGCCCCC       3.22 × 10^−13^       Q9BXK1
  7             Zfx             SSSGCCBVGGCCTS    1.06 × 10^−11^       P17010
  **Liver**                                                            
  1             SP1             GCCCCKCCCCC       7.81 × 10^−13^       P08047
  2             TFAP2B          YGCCCBVRGGCA      4.23 × 10^−12^       Q92481
  3             TFAP2C          YGCCYBVRGGCA      1.87 × 10^−11^       Q92754
  4             TFAP2A          HGCCYSAGGCD       4.97 × 10^−11^       P05549
  5             ZNF740          MCCCCCCCAC        8.99 × 10^−11^       Q8NDX6
  **Lung**                                                             
  1             THAP1           YTGCCCDBA         5.09 × 10^−9^        Q9NVV9
  3             ESR2            AGGTCASVNTGMCCY   1.08 × 10^−8^        Q92731
  4             Zfx             SSSGCCBVGGCCTS    1.44 × 10^−8^        P17010
  5             ZBTB7A          NVCCGGAAGTGSV     1.46 × 10^−8^        O95365
  6             TFAP2A(var.2)   YGCCCBVRGGCR      6.51 × 10^−8^        P05549
  **Muscle**                                                           
  1             SP1             GCCCCKCCCCC       1.45 × 10^−9^        P08047
  2             SP2             GYCCCGCCYCYBSSS   4.21 × 10^−9^        Q02086
  3             SP8             RCCACGCCCMCY      1.15 × 10^−8^        Q8IXZ3
  4             CTCFL           CRSCAGGGGGCRSB    3.44 × 10^−8^        Q8NI51
  5             KLF16           GMCACGCCCCC       4.36 × 10^−7^        Q9BXK1
  **Ovary**                                                            
  1             FOXO3 ^1^       DAAAYA            7.23 × 10^−7^        O43524
  3             KLF16           GMCACGCCCCC       1.93 × 10^−4^        Q9BXK1
  4             FOXC1 ^1^       WAWGTAAAYAW       2.39 × 10^−4^        Q12948
  6             CTCFL           CRSCAGGGGGCRSB    4.38 × 10^−4^        Q8NI51
  7             Arid5a          SYAATATTGVDANH    4.99 × 10^−4^        Q03989

^1^ Transcription factor (TF) motifs that were only detected in one tissue.
